article thumbnail

Public Health Product Hops

Bill of Health

Yet Dmitry Karshtedt held otherwise at the ASLME Health Law Professor’s Conference in Atlanta, GA in 2017. On a panel together, we each presented on topics relating to product hopping, but from very different perspectives. But perhaps other forms of public health benefit would outweigh these harms?

article thumbnail

FDA Issues Final Guidance on Presenting Quantitative Efficacy and Risk Information in Direct-to-Consumer Promotional Labeling and Advertising

Hall Render

The Final Guidance provides recommendations on how to enhance consumer comprehension of promotional materials by making the language and presentation of quantitative information more accessible and consumer-friendly across various media formats. 57 out of 100) or percentages (57%). 57 out of 100) or percentages (57%).

FDA 40
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Unlocking the mRNA Platform Technology: Walking the Talk with Investment Protection

Bill of Health

However, rewards from these government investments are going back into the hands of pharma corporations and shareholders, with little thought given to public needs. Recent Research on Public Funding of mRNA Technology The first of the two new articles is an in-depth empirical study of U.S.

article thumbnail

AI’s Ability to Manipulate Decision Making Requires a Moratorium on Its Use in Obtaining Consent for Biomedical Research

Bill of Health

Public Health Service’s (USPHS) Syphilis Study at Tuskegee , whose revelation to the public sparked today’s legal schema for regulating and protecting the research it funds (the “Common Rule”), as well as research done in anticipation of receiving FDA approval for marketing a new product. While the U.S.

article thumbnail

Pharma & Influencer Marketing: Can They Coexist Ethically?

HIT Consultant

The challenges of pharma influencing also present avenues for influencers to bridge the communication gap between brands and consumers. Their role extends beyond simple promotion—influencing public opinions, driving awareness, and ultimately facilitating a positive impact on public health.

article thumbnail

 Are Hospitals Ready for Alzheimer’s Treatment Approval?

HIT Consultant

However, few health systems, medical practices, or providers are prepared for the extraordinary public interest in a treatment for Alzheimer’s disease – especially not one targeting mild cognitive impairment (MCI) and early dementia due to Alzheimer’s disease – that is likely headed their way soon. billion marketing the medication.

article thumbnail

The Supreme Court Threatens to Undermine Vaccination Decisions Entrusted to the States

Bill of Health

Newsom a legal principle that threatens to upend over a century of legal precedent recognizing the authority of state governments to ensure public health by mandating vaccines. Presently, among the fifty U.S. In 2021, the Supreme Court articulated in Tandon v.

COVID-19 157